GGrantIndex
Sort

51,593 grants matching hepatitis

Molecular Regulation Of RNA Metabolism

$2,160,908
Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

Mechanisms of Atherogenesis in Insulin Resistance

$2,160,116
Ira A Tabas · Columbia University Health Sciences · P01 · FY2007 · HL

Phase 1 study of oral epigallocatechin-3-gallate (EGCG) in IPF patients

$2,152,975
Fernando J Martinez · Weill Medical Coll Of Cornell Univ · R33 · FY2023 · HL

Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases

$2,150,109
T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

HIV Centers for Underrepresented Populations in Research Clinical Trials Unit (CURE CTU)

$2,149,542
Stephen A Spector · University Of California, San Diego · UM1 · FY2023 · AI

HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)

$2,149,178
Stephen A Spector · University Of California, San Diego · UM1 · FY2018 · AI

Drug Abuse, Incarceration & Health Disparities in HIV/AIDS: A Longitudinal Study

$2,148,163
Linda A Teplin · Northwestern University At Chicago · R01 · FY2014 · DA

Structural Biology Of Virus Assembly

$2,147,616
Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2016 · AR

Gene Therapy for Hemophilia

$2,146,255
Stanford University · U01 · FY2005 · HL

Subcutaneous Drug Development for Portal Hypertension Ascites

$2,145,275
Gerardo M. Castillo · Pharmain Corporation · R44 · FY2024 · DK

(HVTN) HIV VACCINE TRIAL UNITS

$2,144,081
Johns Hopkins University · U01 · FY2004 · AI

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$2,141,672
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS

$2,139,983
Stanford University · P01 · FY2003 · CA

Multicenter Aids Cohort Study- Part B (Baltimore Site)

$2,138,626
Johns Hopkins University · U01 · FY2004 · AI

The Asia-Pacific HIV Research Collaboration

$2,138,036
David A Cooper · Foundation For Aids Research · U01 · FY2014 · AI

Xenobiotic receptors

$2,137,676
Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Molecular Regulation Of RNA Metabolism

$2,136,723
Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)

$2,136,131
Charles W. Flexner · Johns Hopkins University · UM1 · FY2018 · AI

Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets

$2,133,247
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2020 · DK

Antiviral targeting to suppress drug resistance

$2,132,587
John Damon Chodera · Sloan-Kettering Inst Can Research · U19 · FY2022 · AI

Systems Biology of Insulin Resistance

$2,132,046
Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R24 · FY2012 · DK

Environmental, Microbial and Mammalian Biomolecular Responses to AhR Ligands

$2,131,730
Norbert E Kaminski · Michigan State University · P42 · FY2022 · ES

Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy

$2,131,355
Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK

The Ohio State University AIDS Clinical Trials Unit

$2,130,218
Susan L Koletar · Ohio State University · U01 · FY2010 · AI

Human Microphysiology Systems Disease Model of Type 2 Diabetes Starting with Liver and pancreatic Islets

$2,127,526
D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2021 · DK